Northern Trust Corp Buys 58,525 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Northern Trust Corp grew its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 15.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 435,688 shares of the company’s stock after acquiring an additional 58,525 shares during the period. Northern Trust Corp owned 0.61% of ASP Isotopes worth $1,974,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Hanson & Doremus Investment Management bought a new position in shares of ASP Isotopes in the fourth quarter worth about $27,000. Avantax Advisory Services Inc. bought a new position in shares of ASP Isotopes in the fourth quarter worth about $45,000. Russell Investments Group Ltd. raised its stake in shares of ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock worth $46,000 after acquiring an additional 3,682 shares during the last quarter. SVB Wealth LLC acquired a new stake in shares of ASP Isotopes during the 4th quarter worth approximately $49,000. Finally, Boston Financial Mangement LLC acquired a new stake in shares of ASP Isotopes during the 4th quarter worth approximately $50,000. 16.80% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lifted their price target on shares of ASP Isotopes from $8.50 to $11.00 and gave the stock a “buy” rating in a research report on Wednesday, May 21st.

ASP Isotopes Stock Up 10.1%

Shares of NASDAQ:ASPI opened at $8.59 on Monday. ASP Isotopes Inc. has a one year low of $1.86 and a one year high of $9.33. The company has a 50 day moving average of $5.57 and a 200-day moving average of $5.44. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The stock has a market cap of $644.78 million, a price-to-earnings ratio of -14.08 and a beta of 3.40.

Insider Transactions at ASP Isotopes

In other news, CEO Paul Elliot Mann sold 316,667 shares of ASP Isotopes stock in a transaction that occurred on Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total transaction of $1,820,835.25. Following the completion of the sale, the chief executive officer now owns 7,948,787 shares in the company, valued at $45,705,525.25. The trade was a 3.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Robert Ainscow sold 66,666 shares of ASP Isotopes stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total transaction of $383,329.50. Following the sale, the chief operating officer now owns 1,553,326 shares of the company’s stock, valued at approximately $8,931,624.50. This represents a 4.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 766,667 shares of company stock worth $4,358,502 in the last quarter. 21.40% of the stock is owned by company insiders.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.